" Satellos Bioscience (TSXV:MSCL) appoints new Chief Technology Officer
Satellos Bioscience (MSCL) has appointed Philip Lambert, Ph.D., as Chief Technology Officer of the company, effective September 27, 2022.
" Resverlogix (TSX:RVX) focuses drug development on COVID-19
Clinical development of Resverlogix’s (RVX) candidate apabetalone will remain focused on preventing and treating post-COVID-19 conditions.
" Lumiera Health (TSXV:NHP) partners with natural health industry leader
Lumiera Health (NHP) has signed an MoU to explore a strategic partnership with one of Quebec’s leaders in the natural health industry.
" BetterLife (CSE:BETR) files a comprehensive patent for BETR-001 and other LSD derivatives
BetterLife Pharma (BETR) filed a PCT patent application and a U.S. application for lysergic acid diethylamide (LSD) derivatives, including 2-bromo-LSD.
" Hemostemix (TSXV:HEM) appoints Dr. Ernst von Schwarz to its Scientific Advisory Board
Hemostemix (HEM) has appointed Dr. Ernst von Schwarz, MD, Ph.D., FESC, FACC, FSCAI to its Scientific Advisory Board.
" Titan Medical (TSX:TMD) appoints Eric Heinz as Vice President, Market and Corporate Development
Titan Medical (TMD) has appointed Eric Heinz as the company’s Vice President, Market and Corporate Development.
" Profound Medical (TSX:PRN) confirms positive trends after four years with TULSA-PRO
Profound Medical (PRN) updates results from the TACT pivotal study were presented for the first time this past weekend.
" Salona Global (TSXV:SGMD) closes acquisition, provides corporate update
Salona Global Medical Device Corporation (SGMD) has closed its previously announced acquisition of DaMar Plastics, a plastics manufacturing business.
" Fennec Pharmaceuticals (TSX:FRX) closes second investment of $20M from Petrichor
Fennec Pharmaceuticals (FRX) has completed the second closing of US$20 million of senior secured promissory notes under Petrichor Healthcare Capital Management.